A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs
Background: To eliminate hepatitis C (HCV) infection as a public health concern by 2030, there is a need to develop comprehensive programs among key populations such as people who use drugs (PWUD). Two highly effective regimens are available for initial therapy: glecaprevir/pibrentasvir (G/P) given...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2024-09-01
|
| Colecção: | Journal of Virus Eradication |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2055664024000256 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|